ClinicalTrials.gg
RecruitingNCT06737770OSTEO-OUTCOMEUpdated Nov 10, 2026

Clinical and Functional Assessment of Patients With Transfemoral Amputation Treated With Osteointegrated Implant

An interventional study of osseointegrated surgery for transfemoral amputation in Prosthesis, Lower Limb Amputation Knee and Amputation; Traumatic, Leg, Lower, sponsored by Istituto Ortopedico Rizzoli. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Istituto Ortopedico Rizzoli · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 9 months later.
Updated Nov 10, 2026Primary completion moved1 site added+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Limb amputation is a traumatic event that significantly reduces the ability to perform daily activities, impairs mobility, and lowers quality of life. In Italy, approximately 4 million people live with disabilities, with 1.2 million having motor disabilities. Among lower limb amputees (around 200,000), most are elderly, with amputations due to diabetic or vascular issues. Other groups include middle-aged adults (often victims of workplace accidents) and young individuals (victims of traffic accidents).

Post-amputation rehabilitation mainly involves the use of prostheses, which, however, can cause skin problems due to the socket (the part that anchors the prosthesis to the residual limb). Among patients using a socket, 34-63% develop chronic skin issues and pain. Complications include excessive sweating, sores, abscesses, and irritation. Additionally, daily volume changes in the residual limb and long-term weight fluctuations further complicate the use of conventional prostheses.

In the last two decades, research groups, assisted by experienced surgeons, have worked to develop implant solutions that bypass the socket and address these issues. One such solution is osteointegrated prostheses, which use the principle of osteointegration to anchor the prosthesis directly to the bone of the residual limb. A metal stem is surgically inserted into the medullary canal of the residual limb and fixed through bone growth, establishing a direct connection between the amputated limb and the external prosthesis.

Osteointegrated prostheses are widely accepted worldwide as a valid alternative to socket prostheses, especially for young and active individuals with transfemoral, transtibial, transhumeral, or transradial amputations not caused by vascular issues. The key benefit of osteointegration is the restoration of load alignment along the anatomical and mechanical axis, improving control of the residual limb during walking, as well as overall functional capacity and quality of life. Other advantages include greater stability, enhanced sitting comfort, a wider range of hip movement, faster attachment and detachment of the prosthesis, and improved body perception. Additionally, the direct contact between the metal stem and the bone generates sensory feedback (osteoperception), allowing the patient to better control the amputated limb by perceiving ground contact through vibrations transmitted to the bone. Osteointegration offers the only viable alternative for prosthetic use in patients with a short residual limb, where conventional socket prostheses would not be suitable.

02

Conditions studied

  • Prosthesis
  • Lower Limb Amputation Knee
  • Amputation; Traumatic, Leg, Lower

Browse trials for

Keywords

  • Osseointegration
03

In context

Amputation, Traumatic

112 studies on the registry are indexed under Amputation, Traumatic; 24 are open to participants now.

This study's planned enrollment of 15 is close to the median of 15 across 75 interventional studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 305 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Subjects of both sexes, aged between 18 and 65 years;
  • Subjects with unilateral transfemoral amputation, following trauma, tumor, infection, or congenital defect;
  • Subjects already scheduled for osteointegrated prosthesis surgery for amputation;
  • \< 35 kg/m²;
  • Difficulty in using the traditional socket prosthesis (pain, reduced mobility, short residual limb, skin infections, ulcers, volume changes in the residual limb);
  • Subjects who have signed and reviewed the study information sheet.

Absolute exclusion criteria:

  • Peripheral vascular diseases;
  • Pregnancy;
  • Rheumatoid arthritis;
  • Neurological deficits;
  • Amputation of the contralateral limb;
  • Active infections;
  • Immunodeficiency;
  • Comorbidities/concurrent disabilities, general or localized (Multiple Sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms, etc.), that may interfere with the study;
  • Presence of uncontrolled psychiatric comorbidities;
  • Declared or evident cognitive deficits that would impair understanding of the tasks required ( ≤ 24);
  • Insufficient degree of cooperation;
  • Length of the bone stump (measured from the lesser trochanter to the apex of the stump) less than 15 cm;
  • Previous radiotherapy on the amputated limb;
  • Ongoing chemotherapy treatments.

Relative exclusion criteria:

  • Smoking;
  • Uncontrolled diabetes;
  • Previous infections;
  • Presence of additional joint prostheses on the same limb;
  • Osteoporosis with a T-score of -2.5 or lower.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    patients undergoing osseointegration surgery for transfemoral amputation

    Procedure: osseointegrated surgery for transfemoral amputation

Interventions

  • Procedureosseointegrated surgery for transfemoral amputation

    osseointegrated surgery for transfemoral amputation

06

What researchers measure

Primary outcomes

  1. EQ-5D-5L

    It is a generic tool for measuring perceived quality of life in relation to health status, divided into 5 domains, each assigned a score ranging from 1 (best possible outcome) to 5 (worst possible outcome): mobility, self-care, daily activities, pain/discomfort, and anxiety/depression. Additionally, there is a domain related to general health, scored from 0 (worst possible health status) to 100 (best possible health status)

    Time frame: 12 months after surgery

Secondary outcomes

  1. Q-TFA

    Assessment of quality of life specifically for amputee subjects through the 'Transfemoral Amputation Questionnaire' (Q-TFA), a questionnaire that evaluates prosthesis use and mobility, as well as the individual's issues and general health.

    Time frame: 12 months after surgery

  2. VAS

    It is a unidimensional quantitative pain rating scale with 10 points. The scale requires the patient to select the number that best describes the intensity of their pain, from 0 to 10, at that specific moment. 0 means no pain, and 10 indicates the worst possible pain.

    Time frame: 12 months after surgery

  3. ABIS

    The Body Image Scale for Amputees is a self-administered questionnaire designed to specifically measure body image perception in amputees from the patient's perspective.

    Time frame: 12 months after surgery

  4. TAPES

    The Trinity Amputation and Prosthesis Experience Scales is a self-administered questionnaire that includes the domains of psychosocial adjustment, activity restriction, and prosthesis satisfaction, each divided into 3 subscales. Additionally, it explores residual pain, phantom limb pain, and other medical issues, thus incorporating both the physical and psychosocial aspects of adaptation.

    Time frame: 12 months after surgery

  5. PWB-PTCQ

    The Psychological Well-Being-Post-Traumatic Changes Questionnaire is a self-assessment tool designed to evaluate perceived changes in psychological well-being following traumatic events. The PWB-PTCQ is based on a well-established theoretical framework of psychological well-being (PWB) and adopts the general format of existing measures of growth.

    Time frame: 12 months after surgery

  6. WHODAS 2.0

    The WHO Disability Assessment Schedule is an assessment questionnaire based on the International Classification of Functioning, Disability and Health (ICF) that measures health and disability status. The questionnaire is designed to assess the level of functioning across six domains: cognitive activities, mobility, self-care, interpersonal relationships, daily living activities, and participation.

    Time frame: 12 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.

Of 38 non-industry interventional studies with no phase under Amputation, Traumatic, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 58. This study's planned 23 months is below that.

Counting every sponsor, half of 46 studies reached it within 27 months; a quarter within 14 and three quarters within 51.

Primary completion moved once since we started tracking on Sep 25, 2026: Oct 2026 → Dec 2026, on Nov 10, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2024
First posted
Dec 17, 2024
StartActual
Jan 31, 2025
Primary completionEst.
Dec 2026was Oct 2026
CompletionEst.
Jan 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • IRCCS Rizzoli Orthopedic Institute · Bologna, Italy
Show 1 removed
  • IRCCS Rizzoli Orthopedic Institute · Bologna, Italy
Nov 10, 2026
Primary completion
Oct 2026→Dec 2026
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    1 site added, 1 site removed
    Show site
    • IRCCS Rizzoli Orthopedic Institute · Bologna, Italy
    Show 1 removed
    • IRCCS Rizzoli Orthopedic Institute · Bologna, Italy
    Primary completion Oct 2026→Dec 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06737770
Responsible party
Stefano Zaffagnini (Full Professor Medicine and Surgery, University of Bologna, Istituto Ortopedico Rizzoli) — Principal investigator
First posted
Dec 17, 2024
Start date
Jan 31, 2025
Primary completion
Dec 2026 (estimated)
Completion
Jan 2027 (estimated)
Last update
Nov 10, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion